State Street’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-8,136
| Closed | -$35K | – | 3694 |
|
|
2016
Q2 | $35K | Sell |
8,136
-157,716
| -95% | -$678K | ﹤0.01% | 3619 |
|
|
2016
Q1 | $932K | Sell |
165,852
-1,183
| -0.7% | -$6.65K | ﹤0.01% | 3234 |
|
|
2015
Q4 | $2.87M | Sell |
167,035
-1,011,037
| -86% | -$17.4M | ﹤0.01% | 2840 |
|
|
2015
Q3 | $24.9M | Buy |
1,178,072
+434,796
| +58% | +$9.17M | ﹤0.01% | 1608 |
|
|
2015
Q2 | $36.8M | Buy |
743,276
+246,658
| +50% | +$12.2M | ﹤0.01% | 1447 |
|
|
2015
Q1 | $38.9M | Buy |
496,618
+23,683
| +5% | +$1.85M | ﹤0.01% | 1386 |
|
|
2014
Q4 | $28.7M | Sell |
472,935
-6,122
| -1% | -$371K | ﹤0.01% | 1532 |
|
|
2014
Q3 | $20.4M | Buy |
479,057
+65,068
| +16% | +$2.77M | ﹤0.01% | 1734 |
|
|
2014
Q2 | $25.6M | Sell |
413,989
-9,910
| -2% | -$612K | ﹤0.01% | 1642 |
|
|
2014
Q1 | $27.6M | Buy |
423,899
+6,396
| +2% | +$416K | ﹤0.01% | 1538 |
|
|
2013
Q4 | $23.5M | Sell |
417,503
-3,174
| -0.8% | -$179K | ﹤0.01% | 1633 |
|
|
2013
Q3 | $25.8M | Buy |
420,677
+80,567
| +24% | +$4.95M | ﹤0.01% | 1545 |
|
|
2013
Q2 | $19.9M | Buy |
+340,110
| New | +$19.9M | ﹤0.01% | 1634 |
|